eFFECTOR Presents Data on the Discovery and Structure of eFT226, a Novel Inhibitor of eIF4A, at the AACR 2018 Annual Meeting

World News: . []

SAN DIEGO April 16 2018 GLOBE NEWSWIRE -- eFFECTOR Therapeutics Inc a leader in the development of selective translation regulators STRs for the treatment of cancer, today announced a podium presentation on the structure and discovery of eFT226,...

More news and information about eFFECTOR Therapeutics

Published By:

Globe Newswire: 13:00 GMT Monday 16th April 2018

Published: .

Search for other references to "effector" on SPi News


Share

Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
 
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 07519380.
 
Privacy Policy | Terms and Conditions | Contact Us